Meta-analysis: Effect of ACE-Inhibitors on Outcomes in Patients with Renal Insufficiency

P and T

Volumn 28, Issue 2, 2003, Pages 98-112

  Terajima, Tomoko ^a   Yamagata, Shin Ichi ^a   Satoh, Nobunori ^a   Ueda, Shiro ^a  

^a NONE

Author keywords

Angiotensin converting enzyme inhibitors; Efficacy; End stage renal failure; Meta analysis; Renal insufficiency; Serum creatinine

Indexed keywords

ACEBUTOLOL; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENAZEPRIL; CAPTOPRIL; CILAZAPRIL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL; NIFEDIPINE; PLACEBO; RAMIPRIL;

ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; HUMAN; KIDNEY FAILURE; META ANALYSIS; TREATMENT OUTCOME;

EID: 0345564881     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Japanese Society for Dialysis Therapy. An overview of dialysis treatment in Japan (as of December 31, 1999) 2001 [in Japanese].
2. Viberti G, Mogensen CE, Groop LC, Pauls JF. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group. JAMA 1994;271(4):275-279.
3. Laffel LM, McGill JB, Gans DJ. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group. Am J Med 1995;99(5):497-504.
4. Bjorck S, Mulec H, Johnsen SA, et al. Renal protective effect of enalapril in diabetic nephropathy. BMJ 1992;304(6823):339-343.
5. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993;329(20):1456-1462.
6. Maschio G, Cagnoli L, Claroni F, et al. ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: A multicentre, randomized, placebo-controlled study. Nephrol Dial Transplant 1994;9(3):265-269.
7. Kaiser BL, Kalil RS, Ma JZ, et al. Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis. Ann Intern Med 1993;118(2):129-138.
8. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157(21):2413-2446.
9. Guidelines Subcommittee of the Japanese Society of Hypertension. Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2000); 2000 [in Japanese].
10. Ando S, Sato H, Ito S. Renal failure. Clin All-round 2000;49(3): 542-545.
11. Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: Is this a cause for concern? Arch Intern Med 2000;160(5):685-693.
12. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-748.
13. Robins J, Greenland S, Breslow NE. A general estimator for the variance of the Mantel-Haenszel odds ratio. Am J Epidemiol 1986;124(5):719-723.
14. Mantel N, Brown C, Byar DP. Tests for homogeneity of effect in an epidemiologic investigation. Am J Epidemiol 1977;106(2):125-129.
15. Agresti A. Categorical Data Analysis. New York: John Wiley & Sons; 1990.
16. Hannedouche T, Landais P, Goldfarb B, et al. Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure. BMJ 1994;309(6958):833-837.
17. Kamper AL, Strandgaard S, Leyssac PP. Effect of enalapril on the progression of chronic renal failure: A randomized controlled trial. Am J Hypertens 1992;5(7):423-430.
18. Cinotti GA, Zucchelli PC. Effect of lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies. Nephrol Dial Transplant 2001;16(5):961-966.
19. Zucchelli P, Zuccala A, Borghi M, et al. Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int 1992;42(2):452-458.
20. Maschio G, Alberti D, Janin G, et al. Effect of the angiotensin-converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting Enzyme Inhibition in Progressive Renal Insufficiency (AIPRI) Study Group. N Engl J Med 1996;334(15):939-945.
21. Ruggenenti P, Perna A, Gherardi G, et al. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 1999;354(9176):359-364.
22. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1997;349(9069):1857-1863.
23. van Essen GG, Apperloo AJ, Rensma PL, et al. Are angiotensin-converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline? Kidney Int Suppl 1997;63:S58-S62.
24. Himmelmann A, Hansson L, Hansson BG, et al. ACE inhibition preserves renal function better than beta-blockade in the treatment of essential hypertension. Blood Press 1995;4(2):85-90.
25. Ihle BU, Whitworth JA, Shahinfar S, et al. Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: A controlled double-blind trial. Am J Kidney Dis 1996;27(4):489-495.
26. Becker GJ, Whitworth JA, Ihle BU, et al. Prevention of progression in non-diabetic chronic renal failure. Kidney Int Suppl 1994;45: S167-S170.
27. Bauer JH, Reams GP, Hewett J, et al. A randomized, double-blind, placebo-controlled trial to evaluate the effect of enalapril in patients with clinical diabetic nephropathy. Am J Kidney Dis 1992;20(5):443-457.
28. Stornello M, Valvo EV, Scapellato L. Angiotensin converting enzyme inhibition in normotensive type II diabetics with persistent mild proteinuria. J Hypertens Suppl 1989;7(6):S314-S315.
29. Jafar TH, Schmid CH, Landa M, et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease: A meta-analysis of patient-level data. Ann Intern Med 2001;135(2): 73-87.
30. Kshirsagar AV, Joy MS, Hogan SL, et al. Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: A systematic overview of randomized placebo-controlled trials. Am J Kidney Dis 2000;35(4):695-707.
31. Giatras I, Lau J, Levey AS. Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: A meta-analysis of randomized trials. Angiotensin-Converting Enzyme Inhibition and Progressive Renal Disease Study Group. Ann Intern Med 1997;127(5):337-345.